Novartis AG NOVNEE.SW Stock
Novartis AG Price Chart
Novartis AG NOVNEE.SW Financial and Trading Overview
| Novartis AG stock price | 90.85 CHF |
| Previous Close | 90.56 CHF |
| Open | 90.78 CHF |
| Bid | 91.09 CHF x N/A |
| Ask | 99 CHF x N/A |
| Day's Range | 90.78 - 91.57 CHF |
| 52 Week Range | 73.45 - 94.09 CHF |
| Volume | 142.94K CHF |
| Avg. Volume | 497.41K CHF |
| Market Cap | 188.71B CHF |
| Beta (5Y Monthly) | 0.47318 |
| PE Ratio (TTM) | 30.551838 |
| EPS (TTM) | 4.03 CHF |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
NOVNEE.SW Valuation Measures
| Enterprise Value | 204.98B CHF |
| Trailing P/E | 30.551838 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.613592 |
| Price/Book (mrq) | 3.6803515 |
| Enterprise Value/Revenue | 3.925 |
| Enterprise Value/EBITDA | 11.025 |
Trading Information
Novartis AG Stock Price History
| Beta (5Y Monthly) | 0.47318 |
| 52-Week Change | 14.57% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 94.09 CHF |
| 52 Week Low | 73.45 CHF |
| 50-Day Moving Average | 89.91 CHF |
| 200-Day Moving Average | 82.96 CHF |
NOVNEE.SW Share Statistics
| Avg. Volume (3 month) | 497.41K CHF |
| Avg. Daily Volume (10-Days) | 484.73K CHF |
| Shares Outstanding | 0 |
| Float | 2.01B |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 3.461 |
| Trailing Annual Dividend Yield | 3.82% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 13.45% |
| Operating Margin (ttm) | 25.46% |
| Gross Margin | 71.16% |
| EBITDA Margin | 35.60% |
Management Effectiveness
| Return on Assets (ttm) | 7.00% |
| Return on Equity (ttm) | 12.35% |
Income Statement
| Revenue (ttm) | 52.22B CHF |
| Revenue Per Share (ttm) | 24.26 CHF |
| Quarterly Revenue Growth (yoy) | 3.10% |
| Gross Profit (ttm) | 36.74B CHF |
| EBITDA | 18.59B CHF |
| Net Income Avi to Common (ttm) | 7.03B CHF |
| Diluted EPS (ttm) | 2.99 |
| Quarterly Earnings Growth (yoy) | 3.20% |
Balance Sheet
| Total Cash (mrq) | 12.19B CHF |
| Total Cash Per Share (mrq) | 5.81 CHF |
| Total Debt (mrq) | 29.2B CHF |
| Total Debt/Equity (mrq) | 56.01 CHF |
| Current Ratio (mrq) | 1.051 |
| Book Value Per Share (mrq) | 24.821 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 15.54B CHF |
| Levered Free Cash Flow (ttm) | 11.48B CHF |
Profile of Novartis AG
| Country | Switzerland |
| State | N/A |
| City | Basel |
| Address | Lichtstrasse 35 |
| ZIP | 4056 |
| Phone | 41 61 324 1111 |
| Website | https://www.novartis.com |
| Industry | Drug Manufacturers-General |
| Sector(s) | Healthcare |
| Full Time Employees | 103000 |
Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally. The company operates through two segments: Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and physicians. It also provides cardiovascular, ophthalmology, neuroscience, immunology, hematology, and solid tumor products. The Sandoz segment develops, manufactures, and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services; and anti-infectives, such as active pharmaceutical ingredients and intermediates primarily antibiotics. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol. Novartis AG was incorporated in 1996 and is headquartered in Basel, Switzerland.
Q&A For Novartis AG Stock
What is a current NOVNEE.SW stock price?
Novartis AG NOVNEE.SW stock price today per share is 90.85 CHF.
How to purchase Novartis AG stock?
You can buy NOVNEE.SW shares on the Swiss exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Novartis AG?
The stock symbol or ticker of Novartis AG is NOVNEE.SW.
Which industry does the Novartis AG company belong to?
The Novartis AG industry is Drug Manufacturers-General.
How many shares does Novartis AG have in circulation?
The max supply of Novartis AG shares is 2.04B.
What is Novartis AG Price to Earnings Ratio (PE Ratio)?
Novartis AG PE Ratio is 22.54342300 now.
What was Novartis AG earnings per share over the trailing 12 months (TTM)?
Novartis AG EPS is 4.03 CHF over the trailing 12 months.
Which sector does the Novartis AG company belong to?
The Novartis AG sector is Healthcare.